Status:
UNKNOWN
Pharmacological Treatment of Children and Adolescents With Severe Mood Dysregulation
Lead Sponsor:
Federal University of Rio Grande do Sul
Conditions:
Severe Mood Dysregulation
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate whether Risperidone is effective in children and adolescents with severe mood dysregulation.
Detailed Description
Severe Mood Dysregulation(SMD) is a new construct in children and adolescents characterized by persistent and non episodic irritability, hyperarousal and emotional reactivity. This is an open label t...
Eligibility Criteria
Inclusion
- Diagnose of Severe Mood Dysregulation
- 7-17 years
- IQ \> 70
Exclusion
- Bipolar disorder
- IQ\<70
- Psychosis
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00825552
Start Date
January 1 2009
End Date
November 1 2010
Last Update
January 21 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90000-010
2
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90350-903